Disease Progression in Multiple Sclerosis: A Literature Review Exploring Patient Perspectives
Open Access
- 1 January 2021
- journal article
- review article
- Published by Taylor & Francis Ltd in Patient Preference and Adherence
- Vol. ume 15, 15-27
- https://doi.org/10.2147/ppa.s268829
Abstract
Purpose: Multiple sclerosis (MS) prognosis is often uncertain. This literature review considers patients’ understanding of, and perspectives on, MS progression to better comprehend the unmet needs of people with MS (PwMS), in order to improve treatment adherence and quality of life (QoL). Methods: Literature searches for peer-reviewed papers concerning patient perspectives on the progression of MS and comparable conditions, published between January 2000 and January 2020, were conducted. Results: Little qualitative evidence exists that examines PwMS’ perspectives on MS progression. The understanding and meaning ascribed to terms such as “disease progression” vary. Some PwMS find disease labels stigmatizing, confusing, and disconnected from reality. The lack of a clear definition of progression and discrepancies between PwMS and healthcare professional (HCP) perspectives may contribute to misunderstanding and poor communication. Patient descriptions of progression and relapses include symptoms in addition to those evaluated by standard severity and disability measures. Compared with HCPs, PwMS are still focused on relapse prevention but place higher priority on QoL and ascribe different relative importance to the causes of poor adherence to treatment plans. PwMS want to discuss progression and likely prognosis. Such communication needs to be personalized and delivered with sensitivity, at an appropriate time. Poor treatment adherence may arise from a lack of understanding and poor communication, particularly around treatment goals. The few studies that directly considered patient perspectives on the progression of comparable conditions supported and extended the perspectives of PwMS. Lack of adequate communication by HCPs was the most common theme. Conclusion: Patient perspectives on disease progression in MS and other chronic progressive conditions are under-investigated and under-reported. The limited evidence available highlights the importance of providing adequate information and effective HCP communication. While further studies are needed, the current evidence base offers information and insights that may help HCPs to enhance patient care, well-being, and treatment adherence.Keywords
This publication has 82 references indexed in Scilit:
- Progression, Symptoms and Psychosocial Concerns among Those Severely Affected by Multiple Sclerosis: A Mixed-Methods Cross-Sectional Study of Black Caribbean and White British PeoplePLOS ONE, 2013
- Determinants of patient adherence: a review of systematic reviewsFrontiers in Pharmacology, 2013
- Patient perceptions of multiple sclerosis and its treatmentPatient Preference and Adherence, 2012
- The MS Choices Survey: findings of a study assessing physician and patient perspectives on living with and managing multiple sclerosisPatient Preference and Adherence, 2011
- Patient preferences for the delivery of bad news - the experience of a UK Cancer CentreEuropean Journal of Cancer Care, 2010
- Central pontine and extrapontine myelinolysis despite careful correction of hyponatremia: clinical and neuropathological findings of a caseNeurological Sciences, 2009
- What can we learn from the personal insights of individuals living and coping with Multiple Sclerosis?Disability and Rehabilitation, 2008
- Breaking the news: A survey of ALS patients and their caregiversAmyotrophic Lateral Sclerosis, 2004
- Chronic illness as biographical disruptionSociology of Health & Illness, 1982